Qisda Corporation (TPE:2352)

CTI BioPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	24,926	26,154	25,473	31,203	17,781	22,540
Short-Term Investments	4,059	3,263	1,341	350.34	4,090	2,742
Trading Asset Securities	185.76	191.44	126.6	81.84	89.92	276.95
Cash & Short-Term Investments	29,171	29,608	26,940	31,635	21,961	25,559
Cash Growth	-2.65%	9.90%	-14.84%	44.05%	-14.08%	56.37%
Accounts Receivable	39,116	42,350	38,042	40,150	33,007	36,502
Other Receivables	1,928	1,681	1,322	2,658	1,156	978.29
Receivables	41,044	44,031	39,364	42,808	34,163	37,480
Inventory	44,678	42,072	37,931	43,870	50,148	35,139
Other Current Assets	3,500	3,577	3,775	3,073	3,648	4,145
Total Current Assets	118,393	119,288	108,010	121,386	109,920	102,324
Property, Plant & Equipment	51,024	50,583	45,612	41,649	37,651	34,895
Long-Term Investments	19,043	18,905	21,135	16,047	22,766	12,212
Goodwill	7,664	7,629	5,921	5,896	5,752	5,271
Other Intangible Assets	5,406	5,672	3,592	4,332	4,787	3,848
Long-Term Deferred Tax Assets	2,243	2,233	2,206	2,086	1,733	1,728
Other Long-Term Assets	1,520	2,095	1,948	2,021	4,601	10,534
Total Assets	205,292	206,405	188,424	193,416	187,211	170,812
Accounts Payable	33,660	34,118	30,468	29,238	40,785	40,526
Short-Term Debt	33,742	32,662	29,920	25,970	24,295	21,132
Current Portion of Long-Term Debt	5,762	4,835	1,556	1,636	1,176	1,063
Current Portion of Leases	944.02	921.97	564.32	531.39	466.25	455.04
Current Income Taxes Payable	1,647	1,585	1,731	4,448	1,541	1,316
Current Unearned Revenue	3,439	3,206	3,036	2,798	2,431	1,862
Other Current Liabilities	18,669	17,070	17,993	20,023	17,639	16,475
Total Current Liabilities	97,863	94,398	85,269	84,644	88,333	82,829
Long-Term Debt	36,223	38,112	33,046	35,082	26,702	22,367
Long-Term Leases	2,839	2,848	1,864	1,987	1,525	1,566
Long-Term Deferred Tax Liabilities	3,052	3,126	2,520	2,032	2,355	1,675
Other Long-Term Liabilities	1,695	1,258	1,207	1,236	1,410	2,712
Total Liabilities	141,672	140,044	124,330	125,478	121,048	111,849
Common Stock	19,274	19,274	19,668	19,668	19,668	19,668
Additional Paid-In Capital	2,248	2,240	1,984	1,949	1,844	1,880
Retained Earnings	15,836	17,485	18,793	24,185	20,778	15,743
Comprehensive Income & Other	-3,606	-3,438	-3,388	-5,076	-833.22	-1,265
Total Common Equity	33,753	35,562	37,057	40,726	41,456	36,026
Minority Interest	29,867	30,799	27,036	27,211	24,706	22,938
Shareholders' Equity	63,620	66,361	64,094	67,937	66,163	58,963
Total Liabilities & Equity	205,292	206,405	188,424	193,416	187,211	170,812
Total Debt	79,510	79,379	66,949	65,205	54,165	46,582
Net Cash (Debt)	-50,339	-49,771	-40,009	-33,570	-32,204	-21,023
Net Cash Per Share	-25.78	-25.37	-20.25	-16.83	-16.16	-10.58
Filing Date Shares Outstanding	1,927	1,927	1,967	1,967	1,967	1,967
Total Common Shares Outstanding	1,927	1,927	1,967	1,967	1,967	1,967
Working Capital	20,530	24,891	22,742	36,742	21,587	19,495
Book Value Per Share	17.51	18.45	18.84	20.71	21.08	18.32
Tangible Book Value	20,683	22,261	27,545	30,499	30,918	26,907
Tangible Book Value Per Share	10.73	11.55	14.00	15.51	15.72	13.68
Land	9,850	9,907	8,853	6,738	6,412	6,438
Buildings	36,873	35,297	32,810	31,867	29,447	26,766
Machinery	40,414	41,367	37,138	31,964	27,538	25,270
Construction In Progress	-	-	-	856.18	918.7	1,110

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.